Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5836 AL 5850

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases

Mayo S, Benito-León J, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

Curr Neuropharmacol. 2021;19(8):1273-1303. doi: 10.2174/1570159X19666201223154009.

Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden

Reffo A, Gabelli C.

J Geriatr Psychiatry Neurol. 2022 Jan;35(1):57-61. doi: 10.1177/0891988720988910. Epub 2021 Jan 19.

Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities

Orad RI, Shiner T.

J Neurol. 2022 Feb;269(2):639-653. doi: 10.1007/s00415-021-10402-2. Epub 2021 Jan 29.

An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology

Tando S, Kasai T, Mizuta I, Takahashi H, Yaoi T, Saito K, Hojo T, Mizuno T, Hasegawa M, Itoh K.

Neuropathology. 2021 Jun;41(3):214-225. doi: 10.1111/neup.12723. Epub 2021 Feb 3.

Electrochemical biosensors for biometal-protein interactions in neurodegenerative diseases

Li S, Kerman K.

Biosens Bioelectron. 2021 May 1;179:113035. doi: 10.1016/j.bios.2021.113035. Epub 2021 Jan 26.

Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression

Krokidis MG, Exarchos TP, Vlamos P.

Math Biosci Eng. 2021 Feb 22;18(2):1813-1832. doi: 10.3934/mbe.2021094.

Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease

Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J, Baban B, Wakade C.

Metab Brain Dis. 2022 Aug;37(6):1687-1696. doi: 10.1007/s11011-021-00735-2. Epub 2021 Apr 21.

Multimodal Imaging in a Patient With Alzheimer Disease and Parkinsonism Because of a Presenilin-1 Mutation

Lu JY, Sun YM, Yen TC, Zuo CT, Wang J.

Clin Nucl Med. 2021 Sep 1;46(9):e483-e484. doi: 10.1097/RLU.0000000000003674.

Ocular biomarkers and their role in the early diagnosis of neurocognitive disorders

Chalkias IN, Tegos T, Topouzis F, Tsolaki M.

Eur J Ophthalmol. 2021 Nov;31(6):2808-2817. doi: 10.1177/11206721211016311. Epub 2021 May 17.

Biomarkers for neurodegenerative diseases

Hansson O.

Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.

Communicating chronic hydrocephalus: A review

Roblot P, Mollier O, Ollivier M, Gallice T, Planchon C, Gimbert E, Danet M, Renault S, Auzou N, Laurens B, Jecko V.

Rev Med Interne. 2021 Nov;42(11):781-788. doi: 10.1016/j.revmed.2021.05.018. Epub 2021 Jun 16.

TSPO imaging in animal models of brain diseases

Van Camp N, Lavisse S, Roost P, Gubinelli F, Hillmer A, Boutin H.

Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):77-109. doi: 10.1007/s00259-021-05379-z. Epub 2021 Jul 10.

Olfaction as an early marker of Parkinson's disease and Alzheimer's disease

Walker IM, Fullard ME, Morley JF, Duda JE.

Handb Clin Neurol. 2021;182:317-329. doi: 10.1016/B978-0-12-819973-2.00030-7.

The APOE ε4 variant and hippocampal atrophy in Alzheimer's disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance

Saeed U, Desmarais P, Masellis M.

Expert Rev Neurother. 2021 Aug;21(8):851-870. doi: 10.1080/14737175.2021.1956904. Epub 2021 Aug 13.

Olfactory dysfunction in aging and neurodegenerative diseases

Dan X, Wechter N, Gray S, Mohanty JG, Croteau DL, Bohr VA.

Ageing Res Rev. 2021 Sep;70:101416. doi: 10.1016/j.arr.2021.101416. Epub 2021 Jul 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias